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the CC BY-NC-ND license (http://creaAbstract Objective: With today’s modern imaging modalities, patients diagnosed with renal
cell carcinoma (RCC) rarely present symptomatically. In some cases, however, they can
develop paraneoplastic syndromes with associated symptoms. To date, only three cases of
RCC presenting with chronic dry cough have been reported. We describe six patients who pre-
sented with cough that improved following radical nephrectomy.
Methods: A retrospective review of patients undergoing partial or radical nephrectomy for
renal masses between January 2015 and March 2016 was performed, and patients presenting
with a cough were examined.
Results: Six patients presented with chronic cough and were discovered to have a large renal
mass. Postoperative spontaneous resolution of cough was noted in all but one patient, in whom
coughing was reduced and limited to the mornings. Cough duration ranged from 3 months to
just over a year. All patients were treated with radical nephrectomy, which was cytoreductive
in four patients. Average tumor size was 10.9 cm (SD Z 2.2 cm). Five of the tumors had clear
cell pathology, and every tumor was Fuhrman grade IV, unifocal, and demonstrated necrosis.
Sarcomatoid features were reported in four of the tumors.
Conclusion: Our study presents the largest series of patients with RCC who presented with a
chronic cough that was significantly improved following radical nephrectomy. We believe
the cause of cough is multifactorial and further investigation is needed to clearly elucidate
the etiology.
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is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Table 1 Baseline patient and disease characteristics.
Characteristics Values
Age (year)a 53.3  8.1
Genderb
Male 5 (83)
Female 1 (17)
Presenting symptomb
Flank pain 1 (17)
Fever 1 (17)
Weight loss 5 (83)
Cough 6 (100)
Weight loss (kg)a 10.5  6.4
Duration of cough (month)a 5.6  4.1
Nephrectomy typeb
Radical 6 (100)
Cytoreductive 4 (67)
Surgical approachb
Open 1 (17)
Laparoscopic 5 (83)
Preoperative lab valuea
Hemoglobin (g/L) 101  19
Total serum calcium (mg/L) 97  8
Alkaline phosphatase (U/L) 145.0  69.5
Follow-up (month)a 7.8  3.4
a Values are presented as mean  SD.
b Values are presented as n (%).
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Renal cell carcinoma (RCC) is often asymptomatic, with an
increasing number of patients being diagnosed incidentally
thanks in large part to increased utilization of abdominal
imaging [1]. When the disease does present symptomati-
cally, however, RCC has variable clinical symptoms,
commonly including hematuria, flank pain, fever, and
weight loss. It is estimated that 10%e40% of patients
develop paraneoplastic syndromes, including metabolic,
hepatic, and hematologic syndromes [2]. Although the lungs
are a common site of metastasis in patients with RCC, res-
piratory paraneoplastic syndromes are rare, with only three
cases of RCC presenting with cough having been reported in
the literature [3e5]. No clear explanation for these coughs
has been elucidated; however, mass effect causing dia-
phragmatic irritation as well as paraneoplastic cytokines or
growth factors have been hypothesized as possible causes.
We present six patients, all of whom presented with cough
that improved following radical nephrectomy.
2. Materials and methods
Following Institutional Review Board approval, data were
prospectively collected from patients undergoing partial
or radical nephrectomy for renal masses between January
2015 and March 2016 from a high volume tertiary care
center. Patient demographics, presenting symptoms,
preoperative lab values, surgical approach (open vs.
laparoscopic), laterality, tumor pathology (size, histology,
Fuhrman grade, pathologic stage, histological features,
and focality), and postoperative follow-up were evalu-
ated. Patients under the age of 18 years and those with no
history of cough were excluded. All patients had more
than 3 months of postoperative surveillance.
Descriptive statistics are presented as counts and per-
centages for categorical variables and as means and stan-
dard deviations (SD) for continuous variables. All
calculations were performed using SPSS, v24.0 (IBM, Chi-
cago, IL, USA).
3. Results
3.1. Patient and disease characteristics
Six patients all presenting with a chief complaint of chronic
dry cough and subsequently found to have large renal mass
were identified. Postoperative spontaneous resolution of
cough was noted in all but one patient, in whom coughing
persisted but was significantly reduced and limited only to
the mornings.
Baseline patient and disease characteristics are pre-
sented in Table 1. Mean age was 53.3 years (SDZ 8.1 years),
and five of the patients were male. Only one patient pre-
sented with flank pain and fever; the remaining patients
reported weight loss averaging 10.5 kg (SDZ 6.4 kg). Cough
duration ranged from 3 months to just over a year. Workup
for cough included a CT scan of the chest and abdomen in
five of the patients, which revealed a renal mass in each
case; the final patient had been taking prednisoneintermittently for several months, and his mass was not
discovered until he presented with flank pain and fever.
All patients were treated with radical nephrectomy, and
the operation was cytoreductive in four cases. Two patients
had pulmonary nodules concerning for metastasis at the
time of nephrectomy, one patient had mediastinal aden-
opathy, and another patient had periaortic adenopathy.
Each nephrectomy began laparoscopically, but one needed
to be converted to open following an intraoperative
complication of hemorrhage leading to hypotension.
Table 2 summarizes tumor characteristics found on sur-
gical pathology. Average tumor size was 10.9 cm
(SDZ 2.2 cm). Fig. 1 shows preoperative CT scans for each
patient. Tumors were clear cell in five of the cases; one was
unclassified due to mixed morphologic and immunohisto-
chemical features. Every tumor was Fuhrman grade IV,
unifocal, and demonstrated necrosis. Sarcomatoid features
were observed in four of the tumors.
3.2. Follow-up
The average follow-up time was 7.8 months (SD Z 3.4
months). Five out of six patients remain completely free of
cough to date. Two of the patients are recovering well and
now on surveillance, with no evidence of local recurrence
or metastasis. They will continue to receive yearly imaging
of the chest, abdomen, and pelvis.
In one patient, two new lesions, sized 2 mm and 6 mm,
were seen in an MRI of the brain 4 months after nephrec-
tomy. He underwent stereotactic radiation to his brain as
well as whole brain radiation therapy. He is currently un-
dergoing chemotherapy with axitinib for his metastatic
RCC. A recent CT scan showed a decrease in lung and
Table 2 Tumor characteristics found on surgical
pathology.
Characteristics Values
Tumor size (cm)a 10.9  2.2
Tumor histologyb
Clear cell 5 (83)
Unclassified 1 (17)
Fuhrman gradeb
IV 6 (100)
Tumor stageb
pT2a 1 (17)
pT2b 1 (17)
pT3a 3 (50)
pT4 1 (17)
Histologic featureb
Positive surgical margin 0 (0)
Sarcomatoid feature 4 (67)
Necrosis 6 (100)
Perinephric fat invasion 2 (33)
Sinus fat invasion 3 (50)
Renal vein invasion 2 (33)
Lymphovascular invasion 2 (33)
Tumor focalityb
Unifocal 6 (100)
Tumor sideb
Right 2 (33)
Left 4 (67)
a Values are presented as mean  SD.
b Values are presented as n (%).
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metastatic growth in the retroperitoneum.
Another patient who had mediastinal adenopathy at the
time of surgery had a subsequent biopsy 1 month after
nephrectomy, which revealed metastatic RCC. This patient
elected treatment with interleukin-2 therapy.
A PET/CT scan was performed just over 1 month
following another patient’s nephrectomy, revealing
metastasis to his right femur and spine as well as the
presence of adenopathy in his supraclavicular and axillary
lymph nodes. Two months following this, he underwent
stereotactic body radiation therapy for his spine and femur.
Follow-up MRI scans reveal radiographic partial regression
of the metastasis in his spine.
Finally, one patient, taking enalapril for hypertension
following nephrectomy, still suffered from a mild cough,
although significantly reduced. He experienced clinical
progression of disease with development of large pleural
effusions; biopsies from the pleural surface revealed pres-
ence of clear cell carcinoma. This patient died from com-
plications related to metastasis.
4. Discussion
Paraneoplastic syndromes associated with RCC can range
widely in their presentation. The six cases described above
represent unusual instances of RCC, with only three similar
cases of patients presenting with a chronic cough having
been previously reported in the literature [3e5]. In all six
cases, evaluation of the cough led to the diagnosis of arenal mass. While the mechanism of the coughing is not
fully understood, it is clear that tumor removal significantly
improved this presenting symptom in each patient as evi-
denced by complete resolution in all but one patient, who
had significant improvement.
One explanation for the coughing may be the mass ef-
fect of these large tumors. Presence of a large mass may
have led to irritation of the diaphragm, causing a reflexive
cough alleviated only by removal of the tumor [6]. In the six
cases in our retrospective review, each of the carcinomas
was relatively large, ranging from 8.5 cm to 14.0 cm. In
none of the cases, however, was there direct extension into
the diaphragm. Historically, prior to the advent of axial
imaging, most renal tumors were detected at a large size. If
mass effect was the primary cause, one would expect many
more cases to have been reported in the literature.
Fujikawa et al. [3] described a patient with a 15 cm
renal mass whose coughing was dramatically reduced
following embolization but prior to nephrectomy. In this
instance, mass effect did not appear to have been the
cause of the cough. This case, as well as the paucity of
coughing as a presenting symptom in individuals with renal
cancer, points to other potential causes.
RCC is known to cause several paraneoplastic syn-
dromes, from hepatic dysfunction to electrolyte abnor-
malities to anemia [2]. The etiology of some of the most
common syndromes has been elucidated. Interleukin-6, for
example, is a cytokine produced by RCCs that has been
linked to higher serum C-reactive protein and haptoglobin
as well as platelet, polymorphonuclear neutrophil, and
monocyte counts [7,8]. Cytokines or growth factors pro-
duced by tumor cells or the immune system have been
shown to produce a cough; indeed, prostaglandins secreted
by RCCs, specifically prostaglandin E2, have been shown to
act upon the cough reflex [9]. As such, it is conceivable that
a factor produced by these cancers may have led to a
paraneoplastic syndrome in the form of a cough. Moreover,
as 67% of our nephrectomies were cytoreductive with syn-
chronous lesions, a clinically significant reduction in
biochemical substrates may also play a role in the abate-
ment of the cough. Interestingly, in one of our patients, the
cough which initially abated after nephrectomy returned
1 year later and correlated with appearance of new
metastasis. Institution of axitinib therapy resulted in sup-
pression of the cough as well as a reduction in the size of his
lung and pleural-based metastasis.
Finally, alterations in the renin-angiotensin system may
be another area of investigation. It is widely known that
angiotensin-converting enzyme inhibitors prevent the
breakdown of bradykinin, leading to cough as a potential
side effect. Increased bradykinin levels may be due to al-
terations in the renin-angiotensin system, leading to the
paraneoplastic cough, but further investigation is necessary
to validate this mechanism.
Without a complete set of lab values for each patient,
we can only hypothesize why they all presented with the
cough. It is important to note, however, that our six pa-
tients each had large tumors, and every tumor was Fuhrman
grade IV and demonstrated necrosis on surgical pathology,
well-known characteristics associated with a poor prog-
nosis. In all but one case, cough resolved completely
following nephrectomy. Despite these similarities, multiple
Figure 1 CT scans of renal masses prior to nephrectomy.
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paraneoplastic syndrome.
5. Conclusion
Chronic dry cough is a known paraneoplastic syndrome in
patients with RCC. This is the largest collection of patients
who presented with this symptom. Further investigation is
needed to elucidate the cause or causes of the cough. Pa-
tients may be counselled that this symptom will likely
improve significantly following radical nephrectomy, even if
cytoreductive in nature.Conflicts of interest
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